Please login to the form below

Not currently logged in
Email:
Password:

Novel endpoints

This page shows the latest Novel endpoints news and features for those working in and with pharma, biotech and healthcare.

J&J’s Erleada first US drug for non-metastatic prostate cancer

J&J’s Erleada first US drug for non-metastatic prostate cancer

This demonstrates the agency’s commitment to using novel endpoints to expedite important therapies to the American public," he added.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Addressing the payer-regulator evidence gap in early-stage cancer Addressing the payer-regulator evidence gap in early-stage cancer

    complications of disease whether measured symptomatically, radiographically, and increasingly with novel measurement techniques. ... endpoints that can better characterise the benefit of new drugs for early disease.

  • Novel endpoints in the digital age Novel endpoints in the digital age

    Novel regulations. Regulators have also welcomed the pharmaceutical industry’s willingness to assess therapeutic benefit using new technologies and novel endpoints. ... Encouraging and supporting the appropriate use of novel endpoints is part of this

  • Rare diseases: redefining medical communications Rare diseases: redefining medical communications

    Additionally, for many rare diseases, well-characterised efficacy endpoints are not available, so new or surrogate endpoints may need to be developed. ... Putting the patient front and centre of the development of these novel endpoints is key for the

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics